Procter & Gamble’s net sales in the third quarter of fiscal year 2026 were $21.2 billion, a 7% increase versus the prior year. Organic sales, which exclude the impacts of foreign exchange and acquisitions and divestitures, increased 3%, driven by a 2% increase from volume and a 1% increase from higher pricing. Mix had a neutral impact on sales for the quarter.

Baby, Feminine and Family Care segment organic sales increased 3% versus year ago. Baby Care organic sales increased low single digits driven by an increase in unit volume, primarily in India, Middle East and Africa and Greater China. Feminine Care organic sales also increased low single digits driven by innovation-based pricing, primarily in North America, and favorable geographic mix, partially offset by a unit volume decline. Family Care organic sales increased mid-single digits driven by strong volume growth due to retail inventory reduction in the prior year, partially offset by merchandising investments.

“We delivered a solid acceleration in top-line results in our fiscal third quarter, with broad-based growth across product categories and regions,” says Shailesh Jejurikar, president and chief executive officer. “We’re increasing investments to accelerate momentum with consumers despite the challenging geopolitical and economic environment, while still maintaining our guidance ranges for the fiscal year. We continue to believe the best path to sustainable, balanced growth is by strengthening execution of our integrated growth strategy. We are confident in the progress we’re making and excited about the longer-term opportunity to leverage P&G’s strengths and unique capabilities to create the CPG company of the future.”